Northwest Biotherapeutics (NWBO) Shares Outstanding (2010 - 2026)

Northwest Biotherapeutics' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $1.6 billion for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 118977.73% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $1.6 billion (up 118977.73% YoY), while the FY2025 annual figure was $1.6 billion, up 126078.26% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $1.6 billion, up from $1.6 billion in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $1.6 billion in Q1 2026, with the low at $959251.0 in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $1.2 million (2024), against an average of $188.5 million.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) rose 8.97% in 2023, then surged 126078.26% in 2025.
• Northwest Biotherapeutics' Shares Outstanding (Entity) stood at $1.0 million in 2022, then advanced by 10.17% to $1.1 million in 2023, then climbed by 10.99% to $1.2 million in 2024, then soared by 126078.26% to $1.6 billion in 2025, then grew by 3.28% to $1.6 billion in 2026.
• Business Quant data shows NWBO's Shares Outstanding (Entity) at $1.6 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.5 million in Q3 2025.